Table 1.
Patient cohort
| Tissue | Copy number analysis | mRNA expression | Overlap |
|---|---|---|---|
| n | 127 | 69 | 59 |
| Gender | |||
| Female | 66 (52%) | 34 (49%) | 31 (53%) |
| Male | 61 (48%) | 34 (49%) | 28 (47%) |
| Unknown | 0 | 1 | 0 |
| Age | |||
| Mean ± SD | 69.5 ± 12.6 | 68.8 ± 11.1 | 68.7 ± 8.0 |
| Tumor grading | |||
| Grade 1 | 1 | 1 | 1 |
| Grade 2 | 106 | 53 | 46 |
| Grade 3 | 18 | 12 | 10 |
| Unknown | 2 | 3 | 2 |
| Lymph node infiltration | |||
| 0 | 58 | 30 | 25 |
| 1 | 30 | 17 | 15 |
| 2 | 35 | 17 | 15 |
| 3 | 1 | 1 | 1 |
| Unknown | 3 | 4 | 3 |
| Site of the primary tumor | |||
| Cecum/ascending/transverse colon | 48 | 26 | 23 |
| Descending/sigmoid colon | 46 | 24 | 24 |
| Rectum | 30 | 17 | 11 |
| Unknown | 3 | 2 | 1 |